News
CRBN/VHL, Targeted Glue™ degraders for oncology and immunology indications Cambridge, UK, 16 July 2025 – Amphista Therapeutics (“the Company” or “Amphista”), a leader in the discovery of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback